A Cost-Effectiveness Model of Tibolone as Treatment for the Prevention of Osteoporotic Fractures in Postmenopausal Women in Sweden

被引:0
作者
Michael Willis
Knut Ödegaard
Ulf Persson
Johan Hedbrant
Dan Mellström
Mats Hammar
机构
[1] IHE,The Swedish Institute for Health Economics
[2] University of Linköping,Systems Analysis Group
[3] Sahlgrenska University Hospital,Geriatric Clinic
[4] University Hospital,Obstetrics and Gynecology, Faculty of Health Sciences
来源
Clinical Drug Investigation | 2001年 / 21卷
关键词
Bone Mineral Density; Incremental Cost; Forearm Fracture; Osteoporotic Woman; Tibolone;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:115 / 127
页数:12
相关论文
共 92 条
[1]  
Cooper C.(1997)The crippling consequences of fractures and their impact on quality of life JAMA 103 12S-19S
[2]  
Melton J.(1995)How many women have osteoporosis now? J Bone Miner Res 10 175-77
[3]  
Geelhoed E.(1994)Cost-effectiveness analysis of hormone replacement therapy and lifestyle intervention for hip fracture Aust J Public Health 18 153-60
[4]  
Harris A.(1997)Epidemiology and predictors of fractures associated with osteoporosis Am J Med 103 3S-8S
[5]  
Prince R.(1998)Lifetime risk of hip fractures is underestimated Osteoporos Int 8 599-603
[6]  
Lips P.(1987)Postmenopausal bone loss is prevented by treatment with low dosage oestrogen with calcium Ann Intern Med 106 40-55
[7]  
Oden A.(1992)The normal menopause transition Am J Hum Biol 4 37-46
[8]  
Dawson A.(1993)Postmenopausal hot flushes and their management Pharmacol Ther 57 347-58
[9]  
Dere W.(1994)Hormone replacement therapy. II. A pharmacoeconomic appraisal of its role in the prevention of postmenopausal osteoporosis and ischaemic heart disease Pharmacoeconomics 5 513-54
[10]  
Ettinger B.(1997)Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation J Bone Miner Res 12 24-35